A NR2E1‐interacting peptide of LSD1 inhibits the proliferation of brain tumour initiating cells

OBJECTIVES: Elimination of brain tumour initiating cells (BTICs) is important for the good prognosis of malignant brain tumour treatment. To develop a novel strategy targeting BTICs, we studied NR2E1(TLX) involved self‐renewal mechanism of BTICs and explored the intervention means. MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Rong, Hameed, Umar Farook Shahul, Sun, Xiang, Moorthy, Balakrishnan Shenbaga, Zhang, Wen, Jeffrey, Philip D., Zhou, Li, Ma, Xin, Chen, Fangjin, Pei, Jianfeng, Giri, Pankaj K., Mou, Yonggao, Swaminathan, Kunchithapadam, Yuan, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816925/
https://www.ncbi.nlm.nih.gov/pubmed/36321378
http://dx.doi.org/10.1111/cpr.13350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816925/
https://www.ncbi.nlm.nih.gov/pubmed/36321378
http://dx.doi.org/10.1111/cpr.13350

Ejemplares similares